Duke Eye Center has become the first academic medical center in the country to implant a new cell-based gene therapy for a rare eye disease called MacTel. This procedure offers hope to patients like ...

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities ...

CDMOs must now offer platform-based manufacturing, simplified tech transfers, AI-driven automation, and robust analytical services. Speed is also critical—traditional 18–24-month timelines are no ...

Market is anticipated to surge from US$ 2.61 billion in 2024 to US$ 5.88 billion by 2033, maintaining a CAGR of 9.46% from ...

As third-quarter earnings continue to roll out, Novartis makes headlines with the second biggest acquisition of the year; ...